 |
|
Incomplete Lupus Erythematosus
Jonathan M. Greer, MD;
Richard S. Panush, MD
Arch Intern Med. 1989;149(11):2473-2476.
Abstract
| |
• Thirty-eight patients with incomplete lupus erythematosus (ILE) (defined as the presence of fewer than four of the criteria of the American College of Rheumatology for systemic lupus erythematosus [SLE]) were identified and compared with 42 patients with SLE. Both groups were comparable with respect to age, sex, and race. Patients with ILE had symptoms for an average of 38 months before seeking rheumatologic care and were followed up for a mean of 19 months; patients with SLE averaged 9 months with symptoms before their diagnosis was made and were followed for a mean of 30 months. Characteristic clinical features of patients with ILE included positive antinuclear antibody titers (83%), polyarticular nonerosive arthritis (47%), and cutaneous findings (61%). These were comparable with findings in the the SLE group. However, patients with ILE had significantly fewer systemic manifestations than did those with SLE. Patients with ILE were treated with nonsteroidal anti-inflammatory drugs more frequently (47%) than were patients with SLE, while the latter group received more topical and oral corticosteorids and immunosuppressives. Only two of the patients with ILE went on to have typical SLE. Thus, ILE may be frequent, mild, and relatively stable or benign, apparently evolving slowly if at all into SLE or other rheumatic disease.
(Arch Intern Med. 1989;149:2473-2476)
Author Affiliations
From the Division of Clinical Immunology, Rheumatology, and Allergy, Department of Medicine, College of Medicine, University of Florida, and Veterans Administration Medical Center, Gainesville, Fla (Drs Greer and Panush); Department of Medicine, University of Medicine and Dentistry of New Jersey–New Jersey Medical School, Newark (Dr Panush); and Department of Medicine, St Barnabas Medical Center, Livingston, NJ (Dr Panush). Dr Greer is now with the Division of Rheumatology, Department of Medicine, Medical Center Clinic PA, Pensacola, Fla.
Footnotes
Accepted for publication July 6,1989.
Presented in part at the Scientific Session, Southeast Region American Rheumatism Association, Nashville, Tenn, December 5,1987.
Reprint requests to Department of Medicine, St Barnabas Medical Center, Livingston, NJ 07039 (Dr Panush).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Defining undifferentiated connective tissue diseases: a challenge for rheumatologists
Mosca et al.
Lupus 2008;17:278-280.
Outcome of incomplete systemic lupus erythematosus after 10 years
Hallengren et al.
Lupus 2004;13:85-88.
ABSTRACT
Rate, pattern and factors related to damage in Brazilian systemic lupus erythematosus patients
Soares et al.
Lupus 2003;12:788-794.
ABSTRACT
Can the weighted criteria improve our ability to capture a larger number of lupus patients into observational and interventional studies? A comparison with the American College of Rheumatology Criteria
Sanchez et al.
Lupus 2003;12:468-470.
ABSTRACT
SLE in three ethnic groups XIII. The 'weighted' criteria as predictors of damage
Alarcon et al.
Lupus 2002;11:329-331.
Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus
Vila et al.
Lupus 2000;9:110-115.
ABSTRACT
The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: Strengths, weaknesses, and opportunities for improvement
Smith and Shmerling
Lupus 1999;8:586-595.
ABSTRACT
Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA
Hochberg et al.
Lupus 1995;4:454-456.
ABSTRACT
1982 Revised Criteria for Classification of Systemic Lupus Erythematosus Ten Years Later
Font and Cervera
Lupus 1993;2:339-341.
The Clinical Significance of Autoantibody Profiles in Patients with Systemic Lupus Erythematosus
Thompson et al.
Lupus 1993;2:15-19.
ABSTRACT
INCOMPLETE LUPUS ERYTHEMATOSUS
JWatch General 1989;1989:2-2.
FULL TEXT
|
